FLASH - Liver Research

Professor Aleksander Krag receives this year's Hagedorn Prize for his major contributions to the early detection and treatment of chronic liver disease. Because of his work, clinicians are better able to identify patients at greatest risk of serious complications and to tailor treatment, improving quality of life for people living with advanced liver disease. Read more: novonordiskfonden.dk/en/news/hagedo…

Is liver steatosis a disease or the emperor’s new clothes? I don’t think it’s meaningful to say 30% of the global population has a liver disease- do you? Is steatosis then a risk factor or a pre-disease? Read the arguments in @JHepatology sciencedirect.com/science/articl…

Phosphatidylethanol (PEth), a direct marker of alcohol consumption (3-4 weeks), are transforming objective measures of alcohol consumption. Check out latest data on its prognostic performance @AGA_Gastro kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

To Screen—or not to screen for for advanced steatotic liver disease? Our new @LancetGastroHep review re-examines Wilson & Jungner (1968), weighs today’s evidence, and proposes 2025 screening criteria @Stine_Johansen_ authors.elsevier.com/c/1lRV98nByrGW…

Happy to share this RCT from @LiverGALAXY in people with ALD Out today in @NaturePortfolio rdcu.be/eujFT The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial

Four successful days at #EASLCongress 2025 in Amsterdam! 💡🌷 Over 7,000 liver professionals joined — and FLASH contributed with 1 oral presentation, 3 poster tours, and 7 posters! 📢🎉 We’re returning home full of insights and inspiration. @OUHhospital @EASLnews

ALB TRIAL investigator meeting in the sun at #EASLCongress @MicrobPredict @FLASH_OUH

We have arrived and we are more than ready for #EASLCongress First is the opening ceremony🥳 @OUHhospital @EASLnews

🧪 New findings published in @JHEP_Reports benchmarking several biomarkers and combinations hereof show soluble TREM2, PRO-C3 & HOMA-IR effectively reflect changes in histological disease activity in MASLD/MASH patients in response to treatment.   doi.org/10.1016/j.jhep…

On Saturday we will be joining the Festival of Science at @SyddanskUni 🎉 💬 Why liver health matters 💥Our research projects and important findings 🎨Liver-activities for the small liver-nerds We look forward to day full of science and fun 🙏 @OUHhospital #Forsk2025 #dkforsk

🎥BTS of a Liver Scan - quick, easy and effective! Watch @MajaThiele and @Kat_Bech demonstrate the use of our fibroscanner - a key tool we use to assess fibrosis.🔎 What is your experience with this tech? Share below!🤗👇 #livertwitter #research #healthcare #tech

@metaboflo @labs_mann @AleksanderKrag @KHThorhauge @OUHhospital @SyddanskUni @ssteigerwald13 @SophiaMaedler Pavel Strnad, Malin Fromme and more 🙏

We’re incredibly proud to co-author this new @Nature paper on alpha1-antitrypsin deficiency 🔬DVP on liver biopsies to 🎯uncover the response to toxic protein buildup 🎯identify compensatory mechanisms Article nature.com/articles/s4158…

Why do some patients remain healthy while others develop severe liver complications despite having the exact same genetic mutation in Alpha-1 Antitrypsin Deficiency?   Proud 😊- Deep Visual Proteomics at single cell level 👉in @Nature   nature.com/articles/s4158…   @labs_mann

🍷🚫EASL will spotlight alcohol harm reduction at #EASLCongress 2025 with key events on 7–8 May, in collaboration with @WHO_Europe The Opening Ceremony on 7 May will feature public health leaders from Spain, Estonia, and WHO Europe. 🌷 On the same day, the #EASLStudio session “Beyond the Myths: Alcohol Harm and Policy Action” will unite experts, policymakers, and patients. 🎙️ On 8 May, the European Alcohol Health Alliance will officially launch, focusing on WHO’s Best Buys, youth protection, and real-world impact through a powerful patient story and expert panel. 🇪🇺🤝 👉Learn more: easlcongress.eu/2025-alcohol-r… @WHO_Europe @AleksanderKrag @SagiZelber @DebbieShawcros1 @EASLedu

Huge congratulations to our amazing colleague, @Johanne_Kragh, on earning her ph.d!🥳 Her research will greatly enhance our understanding of how molecules and bacteria change in steatotic liver disease. We're so proud of you, Johanne!👏 #FLASH #PhDAchievement

Welcome to the team Sofie!👩‍⚕️ A recent graduate now working as a research nurse in our CTU program. We look forward to her valuable contributions!🌟 #newhire #livertwitter #nurses #research

Exciting news about our liverscreening project!📢 DECIDE have completed the final screening of their last patient. In total since 2018= 6,500 participants in the first round of screenings and 1,450 screenings in the second round. Now it’s time to work through the data!📊

Today, we were honored to host Jane Kraglund (regional director), Bo Libergren (chairman, regional council) and the OUH direction to talk about patient-centered research at a high international level 🎯We do it FOR and WITH our patients @OUHhospital @rsyddanmark